<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.openbell.ai/</loc>
    <lastmod>2026-10-09T19:47:24.326Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/support</loc>
    <lastmod>2026-10-09T19:47:24.326Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/privacy</loc>
    <lastmod>2026-10-09T19:47:24.326Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/terms</loc>
    <lastmod>2026-10-09T19:47:24.326Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/feed.json</loc>
    <lastmod>2026-10-09T19:47:24.326Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/DDOG:1791575134332</loc>
    <lastmod>2026-10-09T19:45:34.332Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DDOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Datadog shares are trading higher after CIBC maintained an Outperform rating on the stock and raised its price target from $280 to $315.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MIR:1791574943450</loc>
    <lastmod>2026-10-09T19:42:23.450Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/09/Technical-Price-Graph-And-Indicator--Red.jpg?width=250&amp;height=187</image:loc>
      <image:title>Mirion Stock Climbs: What&amp;#39;s Going On?</image:title>
      <image:caption>Mirion Technologies Inc (NYSE: MIR) shares rose 2.71% to $16.65 following a new stock purchase by Stephanie Link, chief investment officer at Hightower. The company is benefiting from a partnership between Constellation Energy and Alphabet, which will deliver 890 megawatts of nuclear power to the PJM grid. Mirion has regained its 20-day and 50-day simple moving averages, although it remains 12.3% below its 200-day SMA of $18.95, indicating improving momentum despite a larger trend challenge.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/META:1791574606495</loc>
    <lastmod>2026-10-09T19:36:46.495Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/09/Mark-Zuckerberg-Image-On-Mobile-Screen-A.jpg?width=250&amp;height=187</image:loc>
      <image:title>Meta Muse Downloads Are Slowing — And Hunterbrook is Short</image:title>
      <image:caption>Hunterbrook Capital has initiated a short position in Meta Platforms Inc. (NASDAQ: META), citing a decline in downloads and user engagement for the company&#39;s Muse AI agent. Daily downloads averaged 165,000 recently, down 8.1% from the previous week, and daily active users rose at a slower pace, with an average net gain of only 74,000 users per day as of October 6. Following the report, Meta&#39;s stock price decreased by 0.41% to $717.95.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/QSI:1791574296461</loc>
    <lastmod>2026-10-09T19:31:36.461Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/09/Stock-Market-Chart-stock-Market-Data-On-.jpg?width=250&amp;height=187</image:loc>
      <image:title>Quantum-Si Stock Booms: What&amp;#39;s Going On?</image:title>
      <image:caption>Quantum-Si Inc (NASDAQ: QSI) shares surged 27.87% to $1.551 following the announcement that its Proteus protein sequencer can now identify 19 of the 20 amino acids. CEO Jeff Hawkins expressed confidence that the company aims to detect all 20 amino acids by the end of 2026, with a commercial launch of Proteus expected in the second quarter of 2027. The advancement was highlighted at the World HUPO Congress, where interim data showed improved performance metrics for the sequencing technology.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/DD:1791573651888</loc>
    <lastmod>2026-10-09T19:20:51.888Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>JP Morgan Downgrades DuPont de Nemours to Neutral, Lowers Price Target to $145</image:title>
      <image:caption>JP Morgan analyst Chigusa Katoku has downgraded DuPont de Nemours (NYSE: DD) from Overweight to Neutral. The price target for the stock has also been reduced from $172 to $145.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MRNA:1791573492556</loc>
    <lastmod>2026-10-09T19:18:12.556Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/09/Moderna-Inc.jpg?width=250&amp;height=187</image:loc>
      <image:title>Moderna Stock Hits New 52-Week High: What&amp;#39;s Happening?</image:title>
      <image:caption>Moderna Inc (NASDAQ: MRNA) shares have reached a new 52-week high, trading between $219.37 and $219.56, surpassing the previous high of $212.22. The stock&#39;s inclusion in the Nasdaq-100 Index, replacing Warner Bros. Discovery, has contributed to this surge. Additionally, a national initiative led by the NIH to accelerate cancer vaccine breakthroughs, which aligns with Moderna&#39;s focus on mRNA technology, could further enhance the company&#39;s prospects.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ALHC:1791573337133</loc>
    <lastmod>2026-10-09T19:15:37.133Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ALHC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $10</image:title>
      <image:caption>JP Morgan analyst John Stansel has maintained an Overweight rating on Alignment Healthcare (NASDAQ: ALHC) but has lowered the price target from $22 to $10. This adjustment reflects a significant change in the expected valuation of the company.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/DFTX:1791573104911</loc>
    <lastmod>2026-10-09T19:11:44.911Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DFTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>JP Morgan Initiates Coverage On Definium Therapeutics with Overweight Rating, Announces Price Target of $84</image:title>
      <image:caption>JP Morgan has initiated coverage on Definium Therapeutics (NASDAQ: DFTX) with an Overweight rating, setting a price target of $84 for the stock. This move indicates a positive outlook for the company&#39;s future performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MRNA:1791573073012</loc>
    <lastmod>2026-10-09T19:11:13.012Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/09/Two-Vials-Of-The-Moderna-Vaccine-With-A-.jpg?width=250&amp;height=187</image:loc>
      <image:title>A New War on Cancer? NIH&amp;#39;s Vaccine Initiative Sparks Biotech Stock Rally</image:title>
      <image:caption>A new initiative by the National Institutes of Health (NIH) to accelerate personalized cancer vaccine development has led to a rally in biotech stocks, with companies like Moderna, Novavax, BioNTech, Pfizer, Merck, and Vaxcyte seeing significant gains. The initiative, set to launch in December, will focus on cancers such as pancreatic, liver, and colorectal, utilizing mRNA technology to enhance immune responses against existing cancer cells. On the day of the announcement, Vaxcyte shares rose 8.41%, Merck 2.65%, Novavax 16.89%, Moderna 12.15%, Pfizer 1.31%, and BioNTech 5.16%.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CCCC:1791572753431</loc>
    <lastmod>2026-10-09T19:05:53.431Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CCCC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>JP Morgan Initiates Coverage On C4 Therapeutics with Overweight Rating, Announces Price Target of $10</image:title>
      <image:caption>JP Morgan analyst Anupam Rama has initiated coverage on C4 Therapeutics (NASDAQ: CCCC) with an Overweight rating. The firm has set a price target of $10 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/T:1791572708946</loc>
    <lastmod>2026-10-09T19:05:08.946Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/09/Conflict-Duration-Drives-Economic-Risks.jpg?width=250&amp;height=187</image:loc>
      <image:title>Treasury Yields Reach 24-Year Highs, Telecom Stocks Sell Off: This Week On Wall Street</image:title>
      <image:caption>The S&amp;P 500 closed above 7,800 for the first time amidst a backdrop of 24-year high Treasury yields, with the 10-year yield reaching 5.36% and the 30-year at 5.73%. Telecom stocks experienced significant sell-offs, with AT&amp;T and Verizon each dropping 11%, while T-Mobile fell 13%, marking their steepest declines in years. In contrast, PTC Inc. surged 35% after announcing a buyout agreement with Schneider Electric for $205 per share.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/UBER:1791572608919</loc>
    <lastmod>2026-10-09T19:03:28.919Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/09/benzinga-deal-dispatch2.jpg?width=250&amp;height=187</image:loc>
      <image:title>Deal Dispatch: Uber Buys ezCater For $2.3B, Skydance Takes Over Warner Bros., True Food Kitchen Bankruptcy</image:title>
      <image:caption>Uber Technologies has agreed to acquire U.S. catering platform ezCater for $2.3 billion in an all-cash deal, aimed at expanding its rapidly growing delivery business. The transaction is pending regulatory approval and is expected to close in the coming months. Additionally, True Food Kitchen has filed for Chapter 11 bankruptcy protection, closing 12 restaurants while maintaining 34 locations across 14 states, and securing about $20 million in debtor-in-possession financing.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MGM:1791572346239</loc>
    <lastmod>2026-10-09T18:59:06.239Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/09/Man-Playing-Blackjack-At-The-Casino.jpg?width=250&amp;height=187</image:loc>
      <image:title>Something Is Breaking In Casino Stocks: MGM, Wynn Hit Record Losing Streaks</image:title>
      <image:caption>MGM Resorts International (NYSE:MGM) is experiencing a historic 15-week losing streak, down 3.2% in recent trading and a total of 40% during this period, marking the longest decline in its history. Wynn Resorts Ltd. (NASDAQ:WYNN) is also facing challenges with a ninth consecutive weekly decline, down 1.4% this week, while Las Vegas Sands Corp. (NYSE:LVS) is on a seventh-week decline. The overall casino sector is struggling, with Macau gaming revenue down 1.2% in September and a 7.5% drop in visitors to Las Vegas in 2025.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/EMAT:1791572129878</loc>
    <lastmod>2026-10-09T18:55:29.878Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/EMAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>EMAT stock has given up its prior gain. Evolution Metals &amp;amp; Technologies shares were trading higher after the company announced it raised its fiscal 2026 revenue guidance to $10 million to $11 million, up from the previous range of $5 million to $8 million announced on September 10, 2026.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PAA:1791571901388</loc>
    <lastmod>2026-10-09T18:51:41.388Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PAA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Jefferies Initiates Coverage On Plains All American with Buy Rating, Announces Price Target of $27</image:title>
      <image:caption>Jefferies analyst Julien Dumoulin-Smith has initiated coverage on Plains All American (NASDAQ: PAA) with a Buy rating. The firm has set a price target of $27 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/VCRE:1791571793586</loc>
    <lastmod>2026-10-09T18:49:53.586Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VCRE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Jefferies Initiates Coverage On Vicore Pharma Holding with Buy Rating, Announces Price Target of $25</image:title>
      <image:caption>Jefferies analyst Faisal Khurshid has initiated coverage on Vicore Pharma Holding (NASDAQ: VCRE) with a Buy rating. The firm has set a price target of $25 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/USO:1791571786086</loc>
    <lastmod>2026-10-09T18:49:46.086Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>President Trump Posts On Truth Social &amp;#34;I have just concluded a highly successful discussion with President Vladimir Putin, of Russia, wherein it was agreed that Russia will immediately supply over 300,000 Tons of Diesel Fuel to the American and Global Marketplace, another 500,000 Tons during the month of November, and 1,000,000 Tons immediately thereafter. Additionally, based on the condition of their Diesel Refineries, Russia will then deliver, within a short period of time, 3,000,000 Tons of Diesel Fuel.&amp;#34;</image:title>
      <image:caption>Former President Trump announced on Truth Social that he had a successful discussion with Russian President Vladimir Putin regarding the supply of diesel fuel. Russia is set to supply over 300,000 tons of diesel fuel to the American and global markets immediately, with an additional 500,000 tons in November and 1,000,000 tons thereafter. Furthermore, based on the condition of their refineries, Russia plans to deliver an additional 3,000,000 tons of diesel fuel in the near future.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SVRN:1791571550398</loc>
    <lastmod>2026-10-09T18:45:50.398Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SVRN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>SVRN shares are trading higher after the company announced it acquired FastNEAR, a provider of Remote Procedure Call infrastructure that supports applications on the NEAR Protocol.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/EGO:1791571465800</loc>
    <lastmod>2026-10-09T18:44:25.800Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/EGO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Eldorado Gold’s $2B+ Skouries Mine Designated Strategic Project By EU To Strengthen Critical Raw Materials Supply</image:title>
      <image:caption>Eldorado Gold Corporation&#39;s Skouries copper-gold mine in northern Greece has been designated as a Strategic Project by the European Commission under the Critical Raw Materials Act. This designation highlights its significance in enhancing the EU&#39;s domestic supply chains for critical raw materials, particularly copper, which is essential for electrification and renewable energy. The Skouries project represents over $2 billion in investment and is expected to create hundreds of jobs while supporting the region&#39;s economic activity over its 20-year mine life.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/QNCX:1791571393901</loc>
    <lastmod>2026-10-09T18:43:13.901Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/QNCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Quince Therapeutics shares are trading higher after Raymond James initiated its coverage on the stock with an Outperform rating and announced a price target of $72. Also, the company announced that it has changed its name to IRulya Therapeutics, effective on October 12.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/UNH:1791571322899</loc>
    <lastmod>2026-10-09T18:42:02.899Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/UNH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Shares of health insurance companies are trading higher the U.S. CMS awarded five- and four-star ratings to plans offered by UnitedHealth Group, Clover, and Humana among others. Also, Humana reaffirmed its FY26 adjusted EPS guidance and issued optimistic comments about FY27 and FY28.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SU:1791571300683</loc>
    <lastmod>2026-10-09T18:41:40.683Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SU/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>CIBC Maintains Outperformer on Suncor Energy, Raises Price Target to C$115</image:title>
      <image:caption>CIBC has reaffirmed its Outperformer rating on Suncor Energy (TSX: SU) and increased its price target from C$110 to C$115. This adjustment reflects CIBC&#39;s positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/QSI:1791571183392</loc>
    <lastmod>2026-10-09T18:39:43.392Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/QSI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Quantum-Si shares are trading higher after the company announced that it has demonstrated detection of 19 amino acids in its Proteus development program.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/LBRX:1791570955110</loc>
    <lastmod>2026-10-09T18:35:55.110Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LBRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>LB Pharmaceuticals shares are trading higher after Canaccord Genuity initiated its coverage on the stock with a Buy rating and announced a price target of $65.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ASTS:1791570867472</loc>
    <lastmod>2026-10-09T18:34:27.472Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/09/Los-Angeles--California---July-8-2025-As.jpg?width=250&amp;height=187</image:loc>
      <image:title>ASTS Stock Drops 15% on SpaceX Threat: This ETF Holds Both Sides of the Satellite War</image:title>
      <image:caption>AST SpaceMobile Inc. (NASDAQ: ASTS) experienced a significant decline of 15.4% amid heightened competitive concerns following SpaceX&#39;s expansion of its satellite-to-phone capabilities. ASTS represents 4.86% of the Procure Space ETF (NASDAQ: UFO), while SpaceX accounts for 16.73%, meaning ASTS&#39;s drop could lead to an estimated 0.75-percentage-point drag on UFO&#39;s returns. The competitive landscape is further complicated by the FCC&#39;s authorization for SpaceX to deploy a 15,000-satellite Starlink Mobile constellation, which could challenge ASTS&#39;s business model.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CNQ:1791570862600</loc>
    <lastmod>2026-10-09T18:34:22.600Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CNQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>CIBC Maintains Outperformer on Canadian Natural Res, Raises Price Target to C$80</image:title>
      <image:caption>CIBC analyst Dennis Fong has maintained an Outperformer rating on Canadian Natural Resources (TSX: CNQ) and increased the price target from C$75 to C$80. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/RDDT:1791570491130</loc>
    <lastmod>2026-10-09T18:28:11.130Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RDDT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Reddit shares are trading higher after Needham reiterated its Buy rating on the stock and maintained a $300 price target.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/XLY:1791570435984</loc>
    <lastmod>2026-10-09T18:27:15.984Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/09/House-Model-Wrapped-In-Scarf-On-Radiator.jpg?width=250&amp;height=187</image:loc>
      <image:title>Heating Oil Hits $6 A Gallon As Global Supply Shocks Threaten Consumer Spending</image:title>
      <image:caption>Retail heating oil prices are projected to average $5.26 per gallon this winter, a 34% increase from the previous year, with some areas like Massachusetts and New York seeing prices as high as $6.12 and $6.14 respectively. Households using oil for heating may face a 21% increase in spending, with estimates suggesting an additional cost of $960 to $1,200 per household. The rise in prices is attributed to multiple supply shocks, including geopolitical tensions and refinery capacity constraints, which have left about 7 million barrels a day affected. The impact is expected to squeeze consumer budgets, particularly in the Northeast, as higher heating costs coincide with the holiday shopping season.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ICE:1791570409764</loc>
    <lastmod>2026-10-09T18:26:49.764Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/09/Bitcoin-Btc-Cryptocurrency-Coin-With-Alt.jpg?width=250&amp;height=187</image:loc>
      <image:title>Andrew Cuomo Calls 24/7 Stock Trading a ‘Game-Changer’ as ICE, OKX Seek Launch</image:title>
      <image:caption>Andrew Cuomo, co-chair of the joint venture OKXICE between Intercontinental Exchange (NYSE: ICE) and crypto exchange OKX, announced plans to launch a 24/7 tokenized stock trading platform, which he describes as a &#39;transformational game-changer.&#39; The venture has filed with U.S. regulators, aiming to enable global trading of American securities around the clock, potentially injecting billions into the U.S. economy. Cuomo also noted that the SEC&#39;s innovation exemption allows for limited tokenization of stocks, which could lead to significant changes in traditional finance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BIIB:1791570393062</loc>
    <lastmod>2026-10-09T18:26:33.062Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BIIB/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Biogen shares are trading higher after UBS maintained its Buy rating and raised its price target on the stock from $240 to $270.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SAIL:1791570309292</loc>
    <lastmod>2026-10-09T18:25:09.292Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SAIL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>SailPoint shares are trading higher after Cantor Fitzgerald maintained its Overweight rating and raised its price target on the stock from $25 to $27.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ORCL:1791570307370</loc>
    <lastmod>2026-10-09T18:25:07.370Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/09/Konskie--Poland---November-13--2024-Orac.jpg?width=250&amp;height=187</image:loc>
      <image:title>Oracle Stock Drops Thursday: What&amp;#39;s Happening? (CORRECTED)</image:title>
      <image:caption>Oracle Corp (NYSE: ORCL) shares fell on Thursday following revelations that OpenAI&#39;s annualized revenue is approximately $20 billion lower than previously reported figures, now estimated at nearly $50 billion instead of $70 billion. This discrepancy raises concerns about the viability of Oracle&#39;s $300 billion contract with OpenAI for compute power, as it may indicate weaker AI demand. Additionally, Oracle is managing operational challenges by trucking natural gas to data centers due to pipeline delays, which could impact project timelines.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/OKTA:1791570229678</loc>
    <lastmod>2026-10-09T18:23:49.678Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OKTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Okta shares are trading higher after BMO Capital maintained its Outperform rating on the stock and raised its price target from $230 to $245.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/LNAI:1791570124464</loc>
    <lastmod>2026-10-09T18:22:04.464Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LNAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Lunai Bioworks Requests Immediate Nasdaq Trading Suspension Amid Allegations Of Short Selling And Failures To Deliver</image:title>
      <image:caption>On October 9, 2026, Lunai Bioworks, Inc. requested an immediate suspension of trading on Nasdaq due to allegations of substantial short selling and failures to deliver, as outlined in its pending litigation against Seven Points Capital LLC. The request was made to protect investors while Nasdaq and other authorities review the trading records obtained through court-ordered discovery. The company has not yet received a decision from Nasdaq regarding the suspension, and it plans to continue pursuing the litigation.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ZS:1791570088386</loc>
    <lastmod>2026-10-09T18:21:28.386Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ZS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Zscaler shares are trading higher after Citizens maintained its Market Outperform rating and raised its price target on the stock from $210 to $265.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/DDOG:1791570071391</loc>
    <lastmod>2026-10-09T18:21:11.391Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DDOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>CIBC Maintains Outperformer on Datadog, Raises Price Target to $315</image:title>
      <image:caption>CIBC analyst Todd Coupland has maintained an Outperformer rating on Datadog (NASDAQ: DDOG) and increased the price target from $280 to $315. This adjustment reflects a positive outlook for the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/HAE:1791569944927</loc>
    <lastmod>2026-10-09T18:19:04.927Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HAE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Barrington Research Maintains Outperform on Haemonetics, Raises Price Target to $140</image:title>
      <image:caption>Barrington Research analyst Michael Petusky has maintained an &#39;Outperform&#39; rating on Haemonetics (NYSE: HAE) and raised the price target from $118 to $140. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NET:1791569888887</loc>
    <lastmod>2026-10-09T18:18:08.887Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NET/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Cloudflare shares are trading higher after Oppenheimer maintained its Outperform rating on the stock and raised its price target from $380 to $430.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PHG:1791569861070</loc>
    <lastmod>2026-10-09T18:17:41.070Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PHG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>FDA Says Aware That Philips Ultrasound Has A Letter To Customers Recommending All Lumify Diagnostic Ultrasound Systems Have Updated Use Instructions; As Of Sept 29, Philips Ultrasound Reported 8 Serious Injuries, 4 Deaths Associated With Diagnostic Ultrasound System Issue</image:title>
      <image:caption>The FDA has acknowledged that Philips Ultrasound issued a letter to customers recommending updated use instructions for all Lumify Diagnostic Ultrasound Systems. As of September 29, Philips Ultrasound reported eight serious injuries and four deaths linked to issues with the diagnostic ultrasound system. This situation may impact the company&#39;s reputation and stock performance, particularly for the ticker PHG.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/T:1791569821209</loc>
    <lastmod>2026-10-09T18:17:01.209Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/09/Benzinga-Quick-Spark.jpg?width=250&amp;height=187</image:loc>
      <image:title>QUICK SPARK: AT&amp;amp;T Sinks 11% In Worst Day Since 2000 As SpaceX Spectrum Deal Rattles Carriers</image:title>
      <image:caption>AT&amp;T Inc. (NYSE: T) experienced its largest one-day loss since 2000, with shares dropping 11% to $22.14. This decline follows SpaceX&#39;s announcement of a deal to acquire 800 megahertz spectrum licenses, which could enable competition with AT&amp;T and Verizon Communications Inc. (NYSE: VZ), which also fell 11%. AT&amp;T CEO John Stankey has minimized the potential threat from SpaceX&#39;s new service.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SVRN:1791569723533</loc>
    <lastmod>2026-10-09T18:15:23.533Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/09/Analyst.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why Is SVRN Stock Gaining Friday?</image:title>
      <image:caption>SVRN, Inc. (NASDAQ: SVRN) shares rose over 13% on Friday following the announcement of its acquisition of FastNEAR, a provider of Remote Procedure Call infrastructure for the NEAR Protocol. This acquisition enhances SVRN&#39;s strategy by expanding its services beyond digital asset treasury management. The stock is currently trading at $44.29, with a market capitalization of approximately $73.4 million, and the company plans to further invest in FastNEAR&#39;s infrastructure.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MI:1791569666927</loc>
    <lastmod>2026-10-09T18:14:26.927Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>NFT Limited Shares Halted, News Pending</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/GSK:1791569580101</loc>
    <lastmod>2026-10-09T18:13:00.101Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GSK/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Commonwealth Of Pennsylvania: Governor Shapiro Secures Over $800M Investment From GSK To Expand Operations, Creating Over 300 New Jobs; GSK Is Expanding Its Facilities In Upper Merion Township, With Construction Planned To Begin In 2027</image:title>
      <image:caption>Governor Shapiro of Pennsylvania has secured an investment exceeding $800 million from GSK to expand its operations in Upper Merion Township. This expansion is expected to create over 300 new jobs, with construction slated to begin in 2027.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/LBRX:1791569510424</loc>
    <lastmod>2026-10-09T18:11:50.424Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LBRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Canaccord Genuity Initiates Coverage On LB Pharmaceuticals with Buy Rating, Announces Price Target of $65</image:title>
      <image:caption>Canaccord Genuity analyst Sumant Kulkarni has initiated coverage on LB Pharmaceuticals (NASDAQ: LBRX) with a Buy rating. The firm has set a price target of $65 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NVDA:1791569418846</loc>
    <lastmod>2026-10-09T18:10:18.846Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/09/Nvidia-Chip-On-Illuminated-Circuit-Board.jpg?width=250&amp;height=187</image:loc>
      <image:title>NVIDIA&amp;#39;s Rally in Trouble? Analyst Warns of Bull Trap</image:title>
      <image:caption>NVIDIA Corporation (NASDAQ: NVDA) shares fell 0.4% to $229.47, underperforming the broader market, as analysts warn of a potential bull trap following a failed breakout above $235. Chief Market Strategist Jay Woods noted that if selling continues, the stock could drop to the $215 to $220 range, although he remains optimistic about NVIDIA&#39;s long-term prospects. The company is set to report earnings on November 18, with expectations of $2.38 per share and revenue of $104.19 billion, significantly up from last year. Wall Street maintains a Buy consensus rating with an average price target of $342.38.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AMN:1791569226004</loc>
    <lastmod>2026-10-09T18:07:06.004Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AMN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BMO Capital Maintains Outperform on AMN Healthcare Services, Raises Price Target to $43</image:title>
      <image:caption>BMO Capital analyst Jeffrey Silber has maintained an &#39;Outperform&#39; rating on AMN Healthcare Services (NYSE: AMN) and increased the price target from $40 to $43.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/OKTA:1791569112054</loc>
    <lastmod>2026-10-09T18:05:12.054Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OKTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BMO Capital Maintains Outperform on Okta, Raises Price Target to $245</image:title>
      <image:caption>BMO Capital analyst Keith Bachman has maintained an &#39;Outperform&#39; rating on Okta (NASDAQ: OKTA) and raised the price target from $230 to $245. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ATZ:1791569015065</loc>
    <lastmod>2026-10-09T18:03:35.065Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ATZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Canaccord Genuity Maintains Buy on Aritzia, Raises Price Target to C$194</image:title>
      <image:caption>Canaccord Genuity analyst Luke Hannan has maintained a Buy rating on Aritzia (TSX: ATZ) and raised the price target from C$189 to C$194. This adjustment reflects the firm&#39;s positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ARM:1791569010877</loc>
    <lastmod>2026-10-09T18:03:30.877Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ARM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Arm Holdings shares are trading lower after reports suggesting that the company has held early stage discussions to acquire chiplet interconnection maker Eliyan.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/GP:1791568996351</loc>
    <lastmod>2026-10-09T18:03:16.351Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>GreenPower Signs LOI With Invisible Urban Charging, Which Has Secured Over $2.5B, To Develop Integrated Electric Fleet Solutions</image:title>
      <image:caption>GreenPower Motor Company Inc. (NASDAQ: GP) has signed a Letter of Intent (LOI) with Invisible Urban Charging, Inc. (IUC) to collaborate on integrated electric fleet solutions. This partnership aims to combine GreenPower&#39;s electric vehicle platforms with IUC&#39;s charging infrastructure and operational capabilities. IUC has secured over $2.5 billion to support its electric mobility program.</image:caption>
    </image:image>
  </url>
</urlset>